Drug delivery device design company Coalesce Product Development has announced the opening of a new 375 sq m drug delivery development center in Cambridge, UK as well as several management changes, including the appointment of inhalation expert James Tibbatts as Head of Business Development. The company cited increased demand for its Concept to Clinic product development service as the reason for its expansion.
The new facility includes space for design and engineering development as well as a laboratory for drug product characterization and an ISO Class 7 cleanroom for devices meant to be used in early clinical trials and human factors studies.
In addition to Tibbatts, who has extensive experience in inhaler design, most recently with Concept Flow, which he founded in 2007, Coalesce has added medical device manufacturing expert Samantha Shelley as Quality Manager and Colin Dalton as Chairman of the Board.
Dalton has held senior positions with a wide range of companies including Vectura, Quadrant Holdings Cambridge Limited, GSK Biologicals, and PA Consulting over more than 30 years. Since 2011, he has been Company Director of consulting company Margarite Ltd, and he is a member of the Supervisory Board of the Centre for Drug Design and Discovery (CD3).
Coalesce Founder and CEO Dave Ahern commented, “Adding analytical and assembly capabilities to our established expertise in engineering, industrial design, project management, and regulatory affairs gives us more control over the development process and, critically, over the timescales. Having the experts and facilities in-house allows us to fast-track complex drug delivery programs so that our partners can achieve early clinical proof of principle and proceed to manufacturing scale-up with complete confidence in the design.”
Dalton added, “This is an exciting time to be joining the Board of Coalesce. The move to the new development center represents a significant expansion in our capabilities, and we have assembled a very special team to provide a comprehensive development service in response to growing demand.”
Read the Coalesce Product Development press release.
